Skip to main content
ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
241.55
+3.43 (1.44%)
Nov 20, 2024, 4:00 PM EST - Market closed

ResMed Revenue

ResMed had revenue of $1.22B in the quarter ending September 30, 2024, with 11.08% growth. This brings the company's revenue in the last twelve months to $4.81B, up 9.88% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

Revenue (ttm)
$4.81B
Revenue Growth
+9.88%
P/S Ratio
7.38
Revenue / Employee
$481,712
Employees
9,980
Market Cap
35.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Humana 115.01B
GE HealthCare Technologies 19.56B
IQVIA Holdings 15.32B
Haleon 15.07B
Alcon 9.76B
Agilent Technologies 6.50B
Edwards Lifesciences 6.31B
IDEXX Laboratories 3.84B
Revenue Rankings

RMD News

More News